Public procurement
21241372
Ocrelizumabum 30 mg/ml 10 ml
1
Enquiry period
with 20.06.2024 15:53
to 01.07.2024 14:00
to 01.07.2024 14:00
2
Bidding period
with 01.07.2024 14:00
to 22.07.2024 14:00
to 22.07.2024 14:00
20 days left
3
Auction
4
Evaluation
5
Bids have been evaluated
Status
Active
Estimated value without VAT
24 477 666,67 MDL
Period of clarifications:
20 Jun 2024, 15:53 - 1 Jul 2024, 14:00
Submission of proposals:
1 Jul 2024, 14:00 - 22 Jul 2024, 14:00
Auction start date:
will not be used
Supplier technical support:
(+373) 79999801
This procedure is carried out without auction. Your offer is final and must contain the entire list of required documents.
Ocrelizumabum 30 mg/ml 10 ml
Information about customer
Fiscal code/IDNO
Address
MD-2009, MOLDOVA, mun.Chişinău, locality, MD-2009, Republica Moldova, Chişinău str. Cosmescu 3
Web site
---
The contact person
Purchase data
Date created
Date modified
20 Jun 2024, 15:53
Estimated value (without VAT)
24 477 666,67 MDL
Achizitii.md ID
21241372
MTender ID
Type of procedure
Open tender
Award criteria
The lowest price
Delivery address
MD-2009, MOLDOVA, mun.Chişinău, mun.Chişinău, IMSP Institutul de Neurologie și Neurochirurgie “Diomid Gherman”.
Contract period
1 Aug 2024 03:00 - 31 Dec 2025 02:00
List of positions
1)
Title
privind încheierea acordului - cadru “Achiziționarea medicamentului Ocrelizumabum 30 mg/ml 10 ml , necesar IMSP Institutul Neurologie și Neurochirurgie „Diomid Gherman”, pentru anul 2024-2025”.
CPV: 33600000-6 - Pharmaceutical products
Quantity: 360.0
Unit of measurement: Bucata
Subscription settings saved.
Remember, you can always go back to the Subscriptions section and make changes to the frequency of receiving letters, delete or add categories and customers.
Вы уже подписаны на данный CPV код
Documents of the procurement procedure
Anunt de participare din 20.06.2024.signed
Bidding Documents
Anunt de participare din 20.06.2024.signed
20.06.24 15:53
Unfortunately, questions can be asked only during the "Active" period.
Clarifications
Document successfully signed
OK